Three months treatment with chemotherapy and radiotherapy for small cell lung cancer. View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1985-09

AUTHORS

N Thatcher, R Stout, D B Smith, G Grötte, M Winson, H Bassett, K B Carroll

ABSTRACT

Fifty-five patients with inoperable but limited stage small cell carcinoma of the bronchus and a further 15 patients with contra lateral neck nodes, pleural effusions and marrow involvement were entered into the study and treated. The 3 month treatment regimen comprised 3 courses of etoposide with cyclophosphamide at 2.5 gm-2 followed by methotrexate and radiotherapy, no maintenance treatment was given. The complete response rate in the total patient group was 54% and the partial response rate 21%. The median survival was 11 months for the 70 patients, 15 months for the complete responders, and those patients with a bronchoscopically confirmed complete response survived significantly longer. There was no significant difference between the patients with strictly limited stage disease and those in the broader category. Eight patients are tumour free and alive one year or more after the end of treatment. The median followup is 17 months. Twenty-four patients were delayed 1-2 weeks during treatment because of chemotherapy induced toxicity. Six patients died probably of infection associated with leucopaenia. The majority of the patients' Karnofsky performance improved with the treatment as did their breathlessness assessed on a respiratory score. The short intensive chemotherapy regimen of 3 months produced similar results to those following more prolonged treatment regimens. More... »

PAGES

327-332

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1985.197

DOI

http://dx.doi.org/10.1038/bjc.1985.197

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042989161

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2994703


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Small Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Thatcher", 
        "givenName": "N", 
        "type": "Person"
      }, 
      {
        "familyName": "Stout", 
        "givenName": "R", 
        "type": "Person"
      }, 
      {
        "familyName": "Smith", 
        "givenName": "D B", 
        "type": "Person"
      }, 
      {
        "familyName": "Gr\u00f6tte", 
        "givenName": "G", 
        "id": "sg:person.064461615.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.064461615.11"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Winson", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "familyName": "Bassett", 
        "givenName": "H", 
        "type": "Person"
      }, 
      {
        "familyName": "Carroll", 
        "givenName": "K B", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00254545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038550300", 
          "https://doi.org/10.1007/bf00254545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00255764", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041115720", 
          "https://doi.org/10.1007/bf00255764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00254014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004344644", 
          "https://doi.org/10.1007/bf00254014"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1985-09", 
    "datePublishedReg": "1985-09-01", 
    "description": "Fifty-five patients with inoperable but limited stage small cell carcinoma of the bronchus and a further 15 patients with contra lateral neck nodes, pleural effusions and marrow involvement were entered into the study and treated. The 3 month treatment regimen comprised 3 courses of etoposide with cyclophosphamide at 2.5 gm-2 followed by methotrexate and radiotherapy, no maintenance treatment was given. The complete response rate in the total patient group was 54% and the partial response rate 21%. The median survival was 11 months for the 70 patients, 15 months for the complete responders, and those patients with a bronchoscopically confirmed complete response survived significantly longer. There was no significant difference between the patients with strictly limited stage disease and those in the broader category. Eight patients are tumour free and alive one year or more after the end of treatment. The median followup is 17 months. Twenty-four patients were delayed 1-2 weeks during treatment because of chemotherapy induced toxicity. Six patients died probably of infection associated with leucopaenia. The majority of the patients' Karnofsky performance improved with the treatment as did their breathlessness assessed on a respiratory score. The short intensive chemotherapy regimen of 3 months produced similar results to those following more prolonged treatment regimens.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.1985.197", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "52"
      }
    ], 
    "keywords": [
      "Karnofsky performance", 
      "limited stage small cell carcinoma", 
      "small cell lung cancer", 
      "lateral neck nodes", 
      "courses of etoposide", 
      "intensive chemotherapy regimen", 
      "complete response rate", 
      "total patient group", 
      "limited stage disease", 
      "small cell carcinoma", 
      "cell lung cancer", 
      "end of treatment", 
      "month treatment regimen", 
      "complete responders", 
      "chemotherapy regimen", 
      "marrow involvement", 
      "median survival", 
      "stage disease", 
      "months treatment", 
      "complete response", 
      "median followup", 
      "respiratory score", 
      "neck nodes", 
      "pleural effusion", 
      "treatment regimen", 
      "maintenance treatment", 
      "patient group", 
      "treatment regimens", 
      "cell carcinoma", 
      "lung cancer", 
      "patients", 
      "response rate", 
      "months", 
      "regimen", 
      "rate 21", 
      "treatment", 
      "significant differences", 
      "chemotherapy", 
      "radiotherapy", 
      "leucopaenia", 
      "breathlessness", 
      "similar results", 
      "cyclophosphamide", 
      "followup", 
      "regimens", 
      "bronchus", 
      "carcinoma", 
      "effusion", 
      "methotrexate", 
      "infection", 
      "cancer", 
      "responders", 
      "etoposide", 
      "disease", 
      "weeks", 
      "survival", 
      "scores", 
      "toxicity", 
      "involvement", 
      "broad categories", 
      "group", 
      "majority", 
      "years", 
      "course", 
      "response", 
      "differences", 
      "study", 
      "rate", 
      "categories", 
      "end", 
      "nodes", 
      "results", 
      "gm-2", 
      "performance", 
      "stage small cell carcinoma", 
      "contra lateral neck nodes", 
      "partial response rate 21", 
      "response rate 21", 
      "patients' Karnofsky performance", 
      "short intensive chemotherapy regimen", 
      "prolonged treatment regimens"
    ], 
    "name": "Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.", 
    "pagination": "327-332", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042989161"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1985.197"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2994703"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1985.197", 
      "https://app.dimensions.ai/details/publication/pub.1042989161"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_214.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.1985.197"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1985.197'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1985.197'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1985.197'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1985.197'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      22 PREDICATES      124 URIs      113 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1985.197 schema:about N0d2c9565456b4ca3a0aad5ca15f6c3fa
2 N5f0256afbfc64d4193039a077e37c061
3 N66f93183553742f8b2aa3aa76303e141
4 N6c3e411021624b2e8db465e4ec81ca70
5 N71def64606024e8f89037e5bdcf67ce1
6 N9778b99390b84f469185e0e8a1d08e99
7 Na16d2cd9be2c4003943d0f9f05188610
8 Na84b844c213e4fd1af3221221ff9bb6d
9 Na9813624098f4f8286038c3983c6e52e
10 Ne6026b02b833422bb19300c3ce6ec79c
11 Ne7418cd3d67b4c7ca444725a52d6200e
12 Ned67d0f787af44d08f6a00e8ca7cedf3
13 Nf49308c00534420eb3d320fb009d6a8b
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nc03480fb3b8e4030a8cd5ef059d03c38
17 schema:citation sg:pub.10.1007/bf00254014
18 sg:pub.10.1007/bf00254545
19 sg:pub.10.1007/bf00255764
20 schema:datePublished 1985-09
21 schema:datePublishedReg 1985-09-01
22 schema:description Fifty-five patients with inoperable but limited stage small cell carcinoma of the bronchus and a further 15 patients with contra lateral neck nodes, pleural effusions and marrow involvement were entered into the study and treated. The 3 month treatment regimen comprised 3 courses of etoposide with cyclophosphamide at 2.5 gm-2 followed by methotrexate and radiotherapy, no maintenance treatment was given. The complete response rate in the total patient group was 54% and the partial response rate 21%. The median survival was 11 months for the 70 patients, 15 months for the complete responders, and those patients with a bronchoscopically confirmed complete response survived significantly longer. There was no significant difference between the patients with strictly limited stage disease and those in the broader category. Eight patients are tumour free and alive one year or more after the end of treatment. The median followup is 17 months. Twenty-four patients were delayed 1-2 weeks during treatment because of chemotherapy induced toxicity. Six patients died probably of infection associated with leucopaenia. The majority of the patients' Karnofsky performance improved with the treatment as did their breathlessness assessed on a respiratory score. The short intensive chemotherapy regimen of 3 months produced similar results to those following more prolonged treatment regimens.
23 schema:genre article
24 schema:inLanguage en
25 schema:isAccessibleForFree true
26 schema:isPartOf Nc6812c300f8549d6abf4ecf522bf8173
27 Ncc561e0bb2a8461295764039f124a881
28 sg:journal.1017082
29 schema:keywords Karnofsky performance
30 breathlessness
31 broad categories
32 bronchus
33 cancer
34 carcinoma
35 categories
36 cell carcinoma
37 cell lung cancer
38 chemotherapy
39 chemotherapy regimen
40 complete responders
41 complete response
42 complete response rate
43 contra lateral neck nodes
44 course
45 courses of etoposide
46 cyclophosphamide
47 differences
48 disease
49 effusion
50 end
51 end of treatment
52 etoposide
53 followup
54 gm-2
55 group
56 infection
57 intensive chemotherapy regimen
58 involvement
59 lateral neck nodes
60 leucopaenia
61 limited stage disease
62 limited stage small cell carcinoma
63 lung cancer
64 maintenance treatment
65 majority
66 marrow involvement
67 median followup
68 median survival
69 methotrexate
70 month treatment regimen
71 months
72 months treatment
73 neck nodes
74 nodes
75 partial response rate 21
76 patient group
77 patients
78 patients' Karnofsky performance
79 performance
80 pleural effusion
81 prolonged treatment regimens
82 radiotherapy
83 rate
84 rate 21
85 regimen
86 regimens
87 respiratory score
88 responders
89 response
90 response rate
91 response rate 21
92 results
93 scores
94 short intensive chemotherapy regimen
95 significant differences
96 similar results
97 small cell carcinoma
98 small cell lung cancer
99 stage disease
100 stage small cell carcinoma
101 study
102 survival
103 total patient group
104 toxicity
105 treatment
106 treatment regimen
107 treatment regimens
108 weeks
109 years
110 schema:name Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.
111 schema:pagination 327-332
112 schema:productId N056696f911d54c5da0ea414f11f88eaa
113 N1a83cebcaae444ec9742ee18870e7670
114 N8bde5a6354f7422684560e895409373e
115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042989161
116 https://doi.org/10.1038/bjc.1985.197
117 schema:sdDatePublished 2022-01-01T18:05
118 schema:sdLicense https://scigraph.springernature.com/explorer/license/
119 schema:sdPublisher N19072f012ef346aca40122ad5c121322
120 schema:url https://doi.org/10.1038/bjc.1985.197
121 sgo:license sg:explorer/license/
122 sgo:sdDataset articles
123 rdf:type schema:ScholarlyArticle
124 N056696f911d54c5da0ea414f11f88eaa schema:name doi
125 schema:value 10.1038/bjc.1985.197
126 rdf:type schema:PropertyValue
127 N0d2c9565456b4ca3a0aad5ca15f6c3fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Middle Aged
129 rdf:type schema:DefinedTerm
130 N19072f012ef346aca40122ad5c121322 schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 N1a83cebcaae444ec9742ee18870e7670 schema:name pubmed_id
133 schema:value 2994703
134 rdf:type schema:PropertyValue
135 N1f4502fc7d814a179f6fc38ae106b29c rdf:first N29fa106523204c60b8e17fc2d3317452
136 rdf:rest Nee5789baa2944f0baa25ff8a0428dfba
137 N29fa106523204c60b8e17fc2d3317452 schema:familyName Smith
138 schema:givenName D B
139 rdf:type schema:Person
140 N36ab809769f04aaea4de09c3b615d785 schema:familyName Bassett
141 schema:givenName H
142 rdf:type schema:Person
143 N3e6d5fdeedd34cb9b4a8d7981c8543e1 schema:familyName Thatcher
144 schema:givenName N
145 rdf:type schema:Person
146 N479f51c73df844c1afcab67e017436ae rdf:first N36ab809769f04aaea4de09c3b615d785
147 rdf:rest Nfafca25ea478424c989f18eb36101341
148 N5f0256afbfc64d4193039a077e37c061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Female
150 rdf:type schema:DefinedTerm
151 N6376415b4a9b4e3a9f4ad4c2d19598d0 schema:familyName Winson
152 schema:givenName M
153 rdf:type schema:Person
154 N66f93183553742f8b2aa3aa76303e141 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Etoposide
156 rdf:type schema:DefinedTerm
157 N6c3e411021624b2e8db465e4ec81ca70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Aged
159 rdf:type schema:DefinedTerm
160 N6e843f9f51374e8c934050eebee663b7 rdf:first N6376415b4a9b4e3a9f4ad4c2d19598d0
161 rdf:rest N479f51c73df844c1afcab67e017436ae
162 N71def64606024e8f89037e5bdcf67ce1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Humans
164 rdf:type schema:DefinedTerm
165 N8bde5a6354f7422684560e895409373e schema:name dimensions_id
166 schema:value pub.1042989161
167 rdf:type schema:PropertyValue
168 N9778b99390b84f469185e0e8a1d08e99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Carcinoma, Small Cell
170 rdf:type schema:DefinedTerm
171 Na16d2cd9be2c4003943d0f9f05188610 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Methotrexate
173 rdf:type schema:DefinedTerm
174 Na84b844c213e4fd1af3221221ff9bb6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Antineoplastic Combined Chemotherapy Protocols
176 rdf:type schema:DefinedTerm
177 Na9813624098f4f8286038c3983c6e52e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adult
179 rdf:type schema:DefinedTerm
180 Nb6e9568b66f743bf9cf8201f5d86ed8b schema:familyName Stout
181 schema:givenName R
182 rdf:type schema:Person
183 Nc03480fb3b8e4030a8cd5ef059d03c38 rdf:first N3e6d5fdeedd34cb9b4a8d7981c8543e1
184 rdf:rest Nc41a8bea97de4a74bca60e9ef8eeacac
185 Nc41a8bea97de4a74bca60e9ef8eeacac rdf:first Nb6e9568b66f743bf9cf8201f5d86ed8b
186 rdf:rest N1f4502fc7d814a179f6fc38ae106b29c
187 Nc6812c300f8549d6abf4ecf522bf8173 schema:volumeNumber 52
188 rdf:type schema:PublicationVolume
189 Ncc561e0bb2a8461295764039f124a881 schema:issueNumber 3
190 rdf:type schema:PublicationIssue
191 Ndbc0ecab1c5245b6b8f75c31ad84f860 schema:familyName Carroll
192 schema:givenName K B
193 rdf:type schema:Person
194 Ne6026b02b833422bb19300c3ce6ec79c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Lung Neoplasms
196 rdf:type schema:DefinedTerm
197 Ne7418cd3d67b4c7ca444725a52d6200e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Combined Modality Therapy
199 rdf:type schema:DefinedTerm
200 Ned67d0f787af44d08f6a00e8ca7cedf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Cyclophosphamide
202 rdf:type schema:DefinedTerm
203 Nee5789baa2944f0baa25ff8a0428dfba rdf:first sg:person.064461615.11
204 rdf:rest N6e843f9f51374e8c934050eebee663b7
205 Nf49308c00534420eb3d320fb009d6a8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Male
207 rdf:type schema:DefinedTerm
208 Nfafca25ea478424c989f18eb36101341 rdf:first Ndbc0ecab1c5245b6b8f75c31ad84f860
209 rdf:rest rdf:nil
210 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
211 schema:name Medical and Health Sciences
212 rdf:type schema:DefinedTerm
213 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
214 schema:name Oncology and Carcinogenesis
215 rdf:type schema:DefinedTerm
216 sg:journal.1017082 schema:issn 0007-0920
217 1532-1827
218 schema:name British Journal of Cancer
219 schema:publisher Springer Nature
220 rdf:type schema:Periodical
221 sg:person.064461615.11 schema:familyName Grötte
222 schema:givenName G
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.064461615.11
224 rdf:type schema:Person
225 sg:pub.10.1007/bf00254014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004344644
226 https://doi.org/10.1007/bf00254014
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/bf00254545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038550300
229 https://doi.org/10.1007/bf00254545
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/bf00255764 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041115720
232 https://doi.org/10.1007/bf00255764
233 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...